BJ
REGN icon

BlackRock Japan’s Regeneron Pharmaceuticals REGN Stock Holding History

BlackRock Japan’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$37.3M Buy
101,494
+2,070
+2% +$787K 0.12% 197
2016
Q3 		$40M Buy
99,424
+1,824
+2% +$732K 0.14% 173
2016
Q2 		$34.1M Buy
97,600
+1,452
+2% +$559K 0.12% 195
2016
Q1 		$34.7M Sell
96,148
-762
-0.8% -$314K 0.13% 180
2015
Q4 		$52.6M Sell
96,910
-6,120
-6% -$3.32M 0.2% 122
2015
Q3 		$47.9M Sell
103,030
-1,023
-1% -$549K 0.19% 124
2015
Q2 		$53.1M Buy
104,053
+8,032
+8% +$3.92M 0.21% 113
2015
Q1 		$43.4M Sell
96,021
-5,507
-5% -$2.33M 0.17% 142
2014
Q4 		$41.7M Buy
101,528
+8,764
+9% +$3.45M 0.16% 150
2014
Q3 		$33.4M Buy
92,764
+7,226
+8% +$2.42M 0.14% 168
2014
Q2 		$24.2M Sell
85,538
-7,738
-8% -$2.29M 0.11% 215
2014
Q1 		$28M Sell
93,276
-361
-0.4% -$111K 0.13% 195
2013
Q4 		$25.8M Buy
93,637
+3,499
+4% +$1.01M 0.11% 206
2013
Q3 		$28.2M Sell
90,138
-1,082
-1% -$285K 0.13% 178
2013
Q2 		$20.5M Buy
+91,220
New +$21.2M 0.09% 248

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock Japan's REGN Position: Q4 2016 in Review

BlackRock Japan increased its Regeneron Pharmaceuticals (REGN) stake by 2.1% in Q4 2016, buying an estimated $787K and bringing the position to 101,494 shares worth $37.3M. The position accounts for 0.12% of the portfolio, ranked #197.

BlackRock Japan first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $53.1M in Q2 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • BlackRock Japan held 101,494 shares of Regeneron Pharmaceuticals worth $37.3M as of Q4 2016.
  • BlackRock Japan bought 2,070 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $787K.
  • Regeneron Pharmaceuticals made up 0.12% of BlackRock Japan's portfolio in Q4 2016, its #197 holding.
  • BlackRock Japan first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's Regeneron Pharmaceuticals position peaked at $53.1M in Q2 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.